Theratechnologies: Strong Q2 Performance and Positive Outlook Justify Buy Rating

TipRanksJul 12 11:35 ET

JonesTrading Maintains Theratechnologies(THTX.US) With Buy Rating, Maintains Target Price $3

JonesTrading analyst Justin Walsh maintains $Theratechnologies(THTX.US)$ with a buy rating, and maintains the target price at $3.According to TipRanks data, the analyst has a success rate of 37.0%

Moomoo NewsJul 12 11:31 ET · Ratings

Earnings Call Summary | Theratechnologies(THTX.US) Q2 2024 Earnings Conference

The following is a summary of the Theratechnologies Inc. (THTX) Q2 2024 Earnings Call Transcript:Financial Performance:Theratechnologies reported second quarter revenue at $22 million, a 25% year-

moomoo AIJul 10 10:25 ET · Conference Call

Theratechnologies Inc. (THTX) Q2 2024 Earnings Call Transcript

Theratechnologies Inc. (THTX) Q2 2024 Earnings Call Transcript

Earnings Call TranscriptsJul 10 10:05 ET

HIV Medicine Maker Theratechnologies 'Wraps Up Strong Second Quarter,' Stock Soars

On Wednesday, Theratechnologies Inc (NASDAQ:THTX) reported second-quarter 2024 sales of $22.02 million, up 25.5% year over year, beating the consensus of $21.71 million.For the second quarter, net

BenzingaJul 10 09:20 ET

Theratechnologies | 6-K: Report of foreign private issuer (related to financial reporting)

SEC announcementJul 10 08:39 ET · Announcements